AAIC 2025 Abstract
Detecting Amyloid–β Pathology in Subjective Cognitive Decline using novel CSF and plasma biomarkers
By José Contador, Federico Emanuele Pozzi, Gonzalo Sánchez-Benavides, Show 21 more authorsMarc Suárez-Calvet
Study in peopleBiomarkers
Abstract
Background: Cerebrospinal fluid (CSF) and blood‐based biomarkers are essential tools for detecting individuals with cognitive complaints and at‐risk of Alzheimer's disease (AD).
